Miraca Life Sciences Launches InformTx

Miraca Life Sciences has introduced in the U.S. its InformTx therapeutic drug monitoring assays, which are intended for patients with inflammatory bowel disease.

The assays are designed to calculate drug and anti-drug antibody levels for Janssen’s Remicade, AbbVie’s Humira, UCB’s Cimzia, and Takeda Pharmaceuticals’ Entyvio.

A test requires a five to seven milliliter peripheral blood sample and produces results within a five-day time frame. — Anisa Jibrell